Assistant Professor, Surgery, Case Western Reserve University School of Medicine

Obstetrics & Gynecology

Chad Michener is an expert in the field of Obstetrics & Gynecology. He graduated from Wright State University Boonshoft School of Medicine. He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FACOG)". Chad Michener is a published MD as well. He has 29 publications published. The latest was: Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion. Dr. Chad M. Michener is registered with Medicare and accepts Medicare payments.

Publications

---

• Lymph node metastasis and pattern of recurrence in clinically early stage endometrial Cancer with positive lymphovascular space invasion.
• Germline PTEN, SDHB-D, and KLLN alterations in endometrial Cancer patients with cowden and cowden-like syndromes: An international, multicenter, prospective study.
• Type II endometrial Cancer in Hispanic women: Tumor characteristics, treatment and survival compared to non-Hispanic white women.
• Surgical Site Infection in Women Undergoing Surgery for Gynecologic Cancer.
• Endometrial Cancer in Asian and American Indian/Alaskan Native women: Tumor characteristics, treatment and outcome compared to non-Hispanic white women.
• Laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy: initial multi-institutional experience for treatment of invasive Cervical cancer.
• Robotic-assisted laparoscopic hysterectomy: optimizing use of this technology.
• Implementation of Tumor Testing for Lynch Syndrome in Endometrial Cancers at a Large Academic Medical Center.
• Patterns of recurrence in stage I endometrioid endometrial adenoCarcinoma with lymphovascular space invasion.
• Single-Port Gynecologic Surgery With a Novel Surgical Platform.
• Role of the 18:1 lysophosphatidic acid-ovarian Cancer immunoreactive antigen domain containing 1 (OCIAD1)-integrin axis in generating late-stage ovarian Cancer.
• Ovarian Cancer immuno-reactive antigen domain containing 1 (OCIAD1), a key player in ovarian Cancer cell adhesion.
• Modern management of recurrent ovarian Carcinoma. A systematic approach to a chronic disease.
• The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian Cancer.
• Potential markers for detection and monitoring of ovarian Cancer.
• Phase II evaluation of capecitabine in refractory nonsquamous cell Carcinoma of the cervix: a Gynecologic Oncology Group study.
• The Martius flap neovagina revisited.
• Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminishe...
• Second-look operation improves survival in suboptimal, debulked, stage III ovarian Cancer.
• Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast Carcinoma.
• Lysophosphatidic acid and endothelin-induced proliferation of ovarian Cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurv...
• Isolated Cervical metastasis of breast cancer: a case report and review of the literature.
• Ovarian conservation in a woman of reproductive age with müllerian adenosarcoma.
• Total laparoscopic hysterectomy versus laparoscopic-assisted vaginal hysterectomy in endometrial Cancer: surgical and survival outcomes.
• Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial Carcinoma.
• Mullerian adenosarcoma of the uterus associated with long-term oral contraceptive use.
• CCL2 expression in primary ovarian Carcinoma is correlated with chemotherapy response and survival outcomes.
• Genomics and proteomics: application of novel technology to early detection and prevention of Cancer.

Schools

---

• Wright State University Boonshoft School Of Medicine

• Bethesda North Hospital

• Cleveland Clinic

Procedures Preformed

---

• Colpopexy
• Colporrhaphy
• Colposcopy
• Contraceptive Management
• View All

Conditions Treated

---

• Asymptomatic Post-Menopausal Status
• Atrophic Vaginitis
• Carcinoma in Situ
• Cervical Cancer
• View All

Doctors Specialties

---

• Gynecologic Oncology
• Obstetrics
• Gynecology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Fellow (FACS)
• Fellow (FACOG)

Education

---

• Cleveland Clinic Foundation
• Wright State University Boonshoft School of Medicine

Hospital

---

• Cleveland Clinic

Drug Facts

---

NPI NUMBER		1861420093
NPPES Provider LastName		MICHENER
NPPES Provider FirstName		CHAD
NPPES Provider ZIPCode		441950001
NPPES Provider State		OH
Specialty Description		Gynecological/Oncology
Total Claim Count		98.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1861420093
Last Name Of The Provider	MICHENER
First Name Of The Provider	CHAD
View All

Similar Doctors

---

	Dr. Robert L. Debernardo Jr., MD
	Dr. Kristine M. Zanotti, MD This Doctor is OpenDoctor Recommended.
	Dr. Amy A. Merlino, MD This Doctor is OpenDoctor Recommended.
	Dr. Gouri B. Diwadkar, MD This Doctor is OpenDoctor Recommended.
	Dr. Mostafa A. Selim, MD This Doctor is OpenDoctor Recommended.
	Dr. Steven E. Waggoner, MD This Doctor is OpenDoctor Recommended.
	Dr. Ahmad A. Razi, MD This Doctor is OpenDoctor Recommended.
	Dr. Julianne Demartino, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeanne M. Knotek, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph I. Shawi, MD This Doctor is OpenDoctor Recommended.
	Dr. Nancy J. Cossler, MD This Doctor is OpenDoctor Recommended.
	Dr. Lori Weinberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Kimberly S. Gecsi, MD This Doctor is OpenDoctor Recommended.
	Dr. Ori Kushnir, MD
	Dr. Amber A. Bondurant, MD
	Dr. Honor M. Wolfe, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Allison M. Wyman, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog